The importance of maintaining genomic stability is evidenced by the fact that transformed cells often contain a variety of chromosomal abnormalities such as euploidy, translocations, and inversions. Gene amplification is a well-characterized hallmark of genomic instability thought to result from recombination events following the formation of double-strand, chromosomal breaks. Therefore, gene amplification frequency serves as an indicator of genomic stability. The PALA assay is designed to measure directly the frequency with which a specific gene, CAD, is amplified within a cell's genome. We have used the PALA assay to analyse the effects of the human T-cell leukemia virus type I (HTLV-I) oncoprotein, Tax, on genomic amplification. We demonstrate that Tax-expressing cells are five-times more likely to undergo gene amplification than control cells. Additionally, we show that Tax alters the ability of cells to undergo the typical PALA-mediated G 1 phase cell cycle arrest, thereby allowing cells to replicate DNA in the absence of appropriate nucleotide pools. This effect is likely the mechanism by which Tax induces gene amplification. These data suggest that HTLV-I Tax alters the genomic stability of cells, an effect that may play an important role in Tax-mediated, HTLV-I associated cellular transformation. Oncogene (2002 Oncogene ( ) 21, 7230 -7234. doi:10.1038 Keywords: HTLV-I; tax gene amplification; genome stability; PALA; cell cycle
The maintenance of correct genomic composition is important for proper cellular growth control. This idea is supported by the fact that many transformed cells, but rarely normal cells, display characteristics of genomic instability (Smith et al., 1995; reviewed in Tlsty, 1997) , in the form of chromosomal abnormalities, such as deletions, translocations, inversions, or euploidy (reviewed in Lengauer et al., 1998) . These well-characterized observations suggest that the loss of genomic stability is an important step in the transformation process. Gene amplification is a wellstudied marker of genomic instability (Otto et al., 1989) described in many forms of human cancers (Benner et al., 1991) but is seldom observed in normal, or untransformed, cells (Smith et al., 1995; Wright et al., 1990) . The amplification of portions of chromosomes is proposed to initiate in response to chromosomal breaks, which must be resolved by DNA recombination (Coquelle et al., 1997; Kuo et al., 1994; Wettergren et al., 1994; Windle et al., 1991) and results in the formation of expanded chromosomal regions, extrachromosomal elements, or dicentric chromosomes (reviewed in Windle and Wahl, 1992) .
The PALA assay is designed to measure directly the frequency with which gene amplification occurs in mammalian cells in culture (Kempe et al., 1976) . The drug PALA [N-(phosphonoacetyl)-L-aspartate] prevents de novo pyrimidine biosynthesis through inhibition of the tri-functional enzyme CAD (Carbamyl phosphate synthetase/Aspartate transcarbamylase/Dihydroorotase), an essential enzyme in the synthesis of UMP (Swyryd et al., 1974) . When cells are exposed to PALA, the synthesis of pyrimidines is inhibited, resulting in an unbalanced nucleotide pool within the cell (Collins and Stark, 1971; Linke et al., 1996) . This signals a reversible, p53-dependent cell cycle arrest in G 1 phase, preventing cells from entering into S phase and undergoing DNA replication in the absence of appropriate nucleotide reserves (Linke et al., 1996) , an event that could result in the creation of DNA mutations or chromosomal breaks (reviewed in Chernova et al., 1995) . If PALA treatment is maintained, cells eventually die by apoptosis (Di Leonardo et al., 1994) . The only known mechanism by which rodent cells have been shown to become resistant to PALA is through amplification of the CAD gene (Wahl et al., 1979) , which essentially raises the effective cellular concentration of the CAD enzyme to overcome the inhibitory effects of the drug. Therefore, the frequency with which cells develop PALA resistance provides a measure of the frequency with which those cells undergo gene amplification, an indication of the genomic stability of the cells.
The retrovirus human T-cell leukemia virus type I (HTLV-I) is the etiologic agent of the fatal human disease, adult T-cell leukemia (ATL) (Poiesz et al., 1980) . Cells from patients with ATL display a variety of chromosomal abnormalities, such as duplications, deletions, translocations, and euploidy, suggesting that transformation by HTLV-I is associated with genomic instability (reviewed in Kao et al., 2000b) . The viral oncoprotein Tax is essential for HTLV-I-mediated cellular transformation (Nerenberg et al., 1987; Pozzatti et al., 1990; Tanaka et al., 1990; Yamaoka et al., 1992) . Therefore, it is likely that the genomic instability associated with HTLV-I transformation is caused by Tax.
We have examined the ability of the HTLV-I viral oncoprotein, Tax, to alter genomic stability, by measuring its effects on gene amplification using the PALA assay. To perform this assay, the LD 50 (Lethal Dose 50) of PALA, the concentration of drug that results in the inviability of 50% of the cells to be tested, must first be determined. The PALA LD 50 for a pool of multiple clones of CREF (cloned rat embryo fibroblast) cells stably expressing Tax (CREF-Tax) or a control gene (CREF-neo) was determined. The results, depicted in Figure 1 , illustrate that the LD 50 of PALA in both CREF-neo and CREF-Tax cells is approximately 7.5 mM, demonstrating that Tax expression does not affect PALA-induced cellular toxicity in CREF cells.
To determine the effects of Tax expression on gene amplification, we performed the PALA assay on CREF-neo and CREF-Tax cells. For this assay, 1610 5 cells were treated with various concentrations of PALA corresponding to different multiples of the predetermined LD 50 (as shown in Figure 1) As mentioned previously, the only known mechanism by which rodent cells become resistant to PALA is through CAD gene amplification (Wahl et al., 1979) . To verify that the PALA R colonies isolated in the above-described experiment indeed resulted from CAD gene amplification, multiple colonies were isolated, and their CAD gene copy number analysed by Southern blot. Relative to unselected CREF-neo and CREF-Tax cells, the PALA R clones displayed 2 -3-fold increase in CAD gene copy number (Figure 2 ). These data demonstrate that the observed PALA R colonies did indeed result from gene amplification.
Treatment with PALA is known to induce a p53-dependent G 1 cell cycle arrest, in response to unbalanced nucleotide pools (Linke et al., 1996) , to prevent cells from undergoing DNA replication in the (Kao et al., 2000a) were treated with the indicated concentrations of N-(phosphonoacetyl)-L-aspartate (PALA) (Drug Synthesis and Chemistry Branch of the Division of Cancer Treatment at the National Cancer Institute, Bethesda, MD, USA). Seventy-two hours later, cells were stained with Trypan blue, and viable (i.e. nonblue) cells were counted using a hemocytometer. The LD 50 was determined to be the dose at which 50% of the cells were killed by PALA treatment. Results shown are from an average of three independent experiments Figure 2 The CAD gene is amplified in PALA-selected clones. Multiple PALA R colonies were isolated by cylinder cloning. Genomic DNA was isolated from these clones (Clones 1 -37) as well as from unselected CREF-neo and CREF-Tax cells, and a Southern blot for the CAD gene was performed. CAD gene copy number relative to unselected CREF-Tax cells was quantitated using a PhosphoImager a The frequency of PALA R colony formation was determined to be the number of PALA R colonies per 1610 5 cells formed following exposure to the indicated concentration of PALA for 2 -4 weeks. PALA R colonies were scored as any colony comprised of 50 or more cells. The results represent an average of three independent experiments in which each condition was performed in quadruplicate absence of appropriate nucleotide reserves. DNA synthesis under these conditions could result in double-strand chromosomal breaks which may give rise to genomic mutations. Given the data described above demonstrating that Tax expression induces gene amplification, we next examined the effects of Tax on the PALA-induced cell cycle arrest. Asynchronously growing CREF-neo and CREF-Tax cells were treated with 100 mM PALA for 24 h. The cells then were fixed, stained with propidium iodide (PI), and their cell cycle distribution was analysed by flow cytometry (Figure  3a ). Upon treatment with PALA, CREF-neo cells undergo a typical cell cycle arrest as evidenced by an accumulation of cells in G 1 phase (from *50% to *70%) (Figure 3b ). In contrast, CREF-Tax cells do not undergo a G 1 phase cell cycle arrest, but instead show a significant decrease in the percentage of cells in G 1 phase (from *50% to *20%), and a dramatic increase in the percentage of cells in S phase (from *30% to *80%). These results show that Tax alters the ability of cells to properly induce a cell cycle arrest in response to PALA treatment and demonstrates that Tax-expressing cells are able to enter into S phase and initiate DNA replication in the absence of balanced nucleotide pools. This effect could lead to the generation of chromosomal damage (reviewed in Chernova et al., 1995) that ultimately is responsible for the increased gene amplification described above.
It has been demonstrated previously that Tax inhibits the repair of DNA damage, through both the nucleotide excision repair (NER) and base excision repair (BER) pathways (Kao and Marriott, 1999; Philpott and Buehring, 1999) . Using the PALA assay, other NER-deficient cells, such as the Chinese hamster cell line, UV61, displayed a 2 -4-fold increase in gene amplification as compared to its parental, repair proficient cell line, AA8 cells (Mondello et al., 1995) , affirming that the 4 -5-fold increase in gene amplification in NER-deficient CREF-Tax cells is physiologically relevant. These results support the idea that Tax expression confers a repair-deficient phenotype, which may allow for the generation and accumulation of genomic mutations such as gene amplification.
Tax represses the transcriptional activity of p53 by differential phosphorylation (Pise-Masison et al., 1998b) , sequestration of CBP (Ariumi et al., 2000) , or stabilization of the p53 protein (Akagi et al., 1997;  Gartenhaus and Wang, 1995; Reid et al., 1993) . We have shown that, following treatment with PALA, Taxexpressing cells have an altered ability to arrest in G 1 phase, a p53-dependent process Linke et al., 1996) (Figure 3 ). It is likely that the mechanism by which Tax alters the normal PALAdependent cell cycle arrest involves its ability to repress p53 transcriptional activity (Cereseto et al., 1996; Mulloy et al., 1998; Pise-Masison et al., 1998a) . Further studies will be required to determine if repressed p53 activity is responsible for the abnormal response that ultimately induces the generation of mutations in Tax-expressing cells to unbalanced nucleotide pools resulting from PALA treatment. In contrast to the normal cell cycle arrest in G 1 phase following exposure to PALA, Tax-expressing cells appear to accumulate in S phase (Figure 3) , suggesting that these cells are able to initiate DNA replication in the absence of proper nucleotide pools. Under these conditions, the rate of DNA synthesis would be slowed due to a lack of available nucleotides and the time required for cells to complete S phase would increase. This effect likely explains the accumulation of CREF-Tax cells in S phase following PALA treatment. The fact that these cells show an increased DNA content by PI staining demonstrates that they retain the capacity to replicate DNA. The ability of Tax-expressing cells to undergo DNA replication under these conditions can result in the generation of mutations that ultimately give rise to gene amplification (Poupon et al., 1996) .
Cells isolated from ATL patients display a wide variety of chromosomal abnormalities, including deletions, duplications, translocations, and inversions (reviewed in Kao et al., 2000b) , suggesting that HTLV-I affects genomic stability. Given that the HTLV-I viral oncoprotein, Tax, has been shown to be essential for HTLV-I mediated cellular transformation (Nerenberg et al., 1987; Pozzatti et al., 1990; Tanaka et al., 1990; Yamaoka et al., 1992) , it is likely the viral protein responsible for the virally associated genomic instability observed in ATL cells. Our data reported here support such a role for Tax as do observations that Tax-expressing cells have an altered ability to execute the G 1 /S phase DNA damageinduced cell cycle checkpoint in response to UV irradiation which allows the cells to enter into S phase in the presence of unrepaired DNA lesions (Lemoine, unpublished data). This could create an environment in which cells expressing Tax may accumulate mutations over time in response to repeated exposure to DNA damaging agents. Indeed, Tax-expressing cells have been demonstrated to have an increased mutation frequency using other assays (Miyake et al., 1999) . The results of this work demonstrate that a different type of mutation, gene amplification, occurs at a higher frequency in cells expressing Tax. Future studies will be required to determine the effects of HTLV-I Tax on other types of mutations. However, it is likely that this ability of Tax to alter genomic stability resulting in the accumulation of mutations lays an important role in the HTLV-I cellular transformation mediated by Tax.
